Engenco Ltd
ASX:EGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Engenco Ltd
ASX:EGN
|
AU |
|
Jyothy Labs Ltd
BSE:532926
|
IN |
|
Ayala Corp
OTC:AYYLF
|
PH |
|
Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret AS
IST:ANGEN.E
|
TR |
|
Aten International Co Ltd
TWSE:6277
|
TW |
Balance Sheet
Balance Sheet Decomposition
Engenco Ltd
Engenco Ltd
Balance Sheet
Engenco Ltd
| Jun-2005 | Jun-2006 | Jun-2007 | Jun-2008 | Jun-2009 | Jun-2010 | Jun-2011 | Jun-2012 | Jun-2013 | Jun-2014 | Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||
| Cash & Cash Equivalents |
1
|
2
|
0
|
0
|
2
|
3
|
14
|
16
|
5
|
4
|
5
|
12
|
9
|
9
|
24
|
14
|
12
|
5
|
8
|
19
|
|
| Cash |
1
|
2
|
0
|
0
|
2
|
3
|
14
|
16
|
5
|
4
|
5
|
12
|
9
|
9
|
24
|
14
|
12
|
5
|
8
|
19
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
3
|
4
|
20
|
131
|
150
|
44
|
47
|
47
|
31
|
30
|
27
|
19
|
26
|
28
|
30
|
31
|
28
|
36
|
45
|
39
|
|
| Accounts Receivables |
3
|
4
|
17
|
130
|
150
|
44
|
46
|
47
|
30
|
29
|
25
|
19
|
26
|
28
|
30
|
31
|
28
|
36
|
45
|
39
|
|
| Other Receivables |
0
|
0
|
3
|
1
|
0
|
0
|
1
|
0
|
1
|
1
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
3
|
7
|
15
|
65
|
52
|
44
|
51
|
45
|
39
|
34
|
29
|
26
|
29
|
34
|
37
|
42
|
46
|
47
|
60
|
61
|
|
| Other Current Assets |
0
|
0
|
2
|
2
|
2
|
3
|
3
|
2
|
1
|
1
|
1
|
9
|
3
|
3
|
2
|
4
|
2
|
2
|
2
|
3
|
|
| Total Current Assets |
7
|
13
|
36
|
198
|
206
|
94
|
115
|
110
|
76
|
70
|
62
|
66
|
67
|
74
|
93
|
92
|
88
|
90
|
115
|
122
|
|
| PP&E Net |
2
|
3
|
35
|
35
|
46
|
83
|
95
|
92
|
61
|
57
|
26
|
18
|
17
|
17
|
12
|
39
|
43
|
41
|
38
|
49
|
|
| PP&E Gross |
2
|
3
|
35
|
35
|
46
|
83
|
95
|
92
|
61
|
57
|
26
|
0
|
0
|
0
|
12
|
39
|
43
|
41
|
38
|
49
|
|
| Accumulated Depreciation |
1
|
1
|
8
|
19
|
25
|
44
|
46
|
50
|
41
|
49
|
58
|
0
|
0
|
0
|
74
|
80
|
84
|
85
|
88
|
92
|
|
| Intangible Assets |
0
|
0
|
0
|
13
|
18
|
15
|
13
|
11
|
29
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Goodwill |
0
|
9
|
76
|
80
|
85
|
37
|
36
|
33
|
33
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
3
|
|
| Note Receivable |
0
|
0
|
0
|
2
|
3
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
2
|
10
|
22
|
11
|
14
|
8
|
0
|
0
|
0
|
0
|
0
|
6
|
7
|
12
|
16
|
17
|
17
|
15
|
|
| Other Assets |
0
|
9
|
76
|
80
|
85
|
37
|
36
|
33
|
33
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
3
|
|
| Total Assets |
9
N/A
|
26
+187%
|
150
+481%
|
344
+130%
|
380
+10%
|
242
-36%
|
273
+13%
|
254
-7%
|
141
-44%
|
130
-8%
|
90
-31%
|
85
-5%
|
85
0%
|
97
+14%
|
112
+16%
|
144
+28%
|
146
+2%
|
151
+3%
|
174
+15%
|
190
+9%
|
|
| Liabilities | |||||||||||||||||||||
| Accounts Payable |
1
|
3
|
12
|
23
|
51
|
38
|
20
|
21
|
12
|
13
|
12
|
11
|
16
|
15
|
16
|
14
|
14
|
19
|
24
|
20
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
3
|
2
|
0
|
3
|
2
|
|
| Short-Term Debt |
0
|
2
|
2
|
12
|
24
|
29
|
4
|
40
|
23
|
23
|
20
|
0
|
4
|
0
|
0
|
0
|
0
|
0
|
13
|
10
|
|
| Current Portion of Long-Term Debt |
1
|
1
|
4
|
32
|
105
|
52
|
28
|
21
|
1
|
0
|
0
|
17
|
0
|
0
|
0
|
3
|
4
|
4
|
4
|
5
|
|
| Other Current Liabilities |
2
|
4
|
8
|
33
|
41
|
31
|
12
|
16
|
13
|
14
|
11
|
7
|
7
|
7
|
9
|
12
|
11
|
15
|
20
|
28
|
|
| Total Current Liabilities |
3
|
10
|
26
|
100
|
221
|
150
|
64
|
98
|
48
|
50
|
43
|
35
|
28
|
22
|
27
|
32
|
31
|
38
|
62
|
66
|
|
| Long-Term Debt |
3
|
12
|
32
|
98
|
20
|
32
|
22
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
18
|
17
|
16
|
13
|
23
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
2
|
4
|
2
|
2
|
2
|
1
|
1
|
0
|
0
|
1
|
1
|
0
|
0
|
1
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
3
|
3
|
3
|
1
|
1
|
6
|
6
|
6
|
6
|
6
|
6
|
6
|
6
|
6
|
6
|
|
| Other Liabilities |
0
|
0
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
0
|
0
|
0
|
0
|
1
|
4
|
4
|
4
|
5
|
5
|
|
| Total Liabilities |
7
N/A
|
23
+231%
|
58
+159%
|
200
+244%
|
245
+23%
|
191
-22%
|
92
-52%
|
106
+14%
|
51
-51%
|
51
N/A
|
39
-25%
|
31
-21%
|
22
-27%
|
18
-20%
|
22
+24%
|
49
+123%
|
46
-6%
|
52
+13%
|
74
+41%
|
88
+18%
|
|
| Equity | |||||||||||||||||||||
| Common Stock |
0
|
0
|
81
|
118
|
119
|
153
|
275
|
275
|
302
|
302
|
302
|
302
|
303
|
303
|
303
|
303
|
303
|
304
|
304
|
304
|
|
| Retained Earnings |
2
|
3
|
10
|
26
|
15
|
102
|
94
|
127
|
213
|
224
|
252
|
247
|
240
|
224
|
213
|
209
|
203
|
205
|
204
|
201
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Total Equity |
2
N/A
|
3
+50%
|
92
+2 679%
|
144
+57%
|
135
-7%
|
51
-62%
|
181
+256%
|
149
-18%
|
90
-40%
|
79
-13%
|
51
-35%
|
55
+8%
|
63
+14%
|
79
+26%
|
90
+14%
|
94
+5%
|
100
+6%
|
99
-1%
|
100
+1%
|
103
+3%
|
|
| Total Liabilities & Equity |
9
N/A
|
26
+187%
|
150
+481%
|
344
+130%
|
380
+10%
|
242
-36%
|
273
+13%
|
254
-7%
|
141
-44%
|
130
-8%
|
90
-31%
|
85
-5%
|
85
0%
|
97
+14%
|
112
+16%
|
144
+28%
|
146
+2%
|
151
+3%
|
174
+15%
|
190
+9%
|
|
| Shares Outstanding | |||||||||||||||||||||
| Common Shares Outstanding |
13
|
13
|
15
|
21
|
22
|
40
|
150
|
150
|
311
|
311
|
311
|
311
|
313
|
313
|
313
|
313
|
313
|
315
|
316
|
316
|
|